JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
CALL
Celestica
CLS
$42.3B
| $1.34M | ﹤0.01% |
14,500
-161,200
| -92% | -$12.6M |
|
4252
PUT
NetEase
NTES
$80.1B
| $1.34M | ﹤0.01% |
15,000
| – | – |
|
4253
Herbalife
HLF
$1.29B
| $1.34M | ﹤0.01% |
199,737
-167,859
| -46% | -$1.25M |
|
|
BKV
4254
BKV Corp
BKV
$2.93B
| $1.33M | ﹤0.01% |
+56,087
| New | +$1.14M |
|
4255
Sportradar
SRAD
$4.09B
| $1.33M | ﹤0.01% |
76,890
+24,106
| +46% | +$364K |
|
4256
iShares Fallen Angels USD Bond ETF
FALN
$1.61B
| $1.33M | ﹤0.01% |
49,817
-134,243
| -73% | -$3.63M |
|
4257
MVB Financial
MVBF
$398M
| $1.33M | ﹤0.01% |
64,244
+18,318
| +40% | +$378K |
|
4258
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $1.33M | ﹤0.01% |
36,543
+31,865
| +681% | +$1.26M |
|
4259
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.66B
| $1.33M | ﹤0.01% |
46,733
-5,619
| -11% | -$166K |
|
4260
CALL
Marqeta
MQ
$1.7B
| $1.33M | ﹤0.01% |
+87,500
| New | +$1.54M |
|
4261
Ovid Therapeutics
OVID
$553M
| $1.32M | ﹤0.01% |
1,418,306
-45,532
| -3% | -$51K |
|
4262
Johnson Outdoors
JOUT
$505M
| $1.32M | ﹤0.01% |
40,101
-3,194
| -7% | -$109K |
|
4263
Dimensional Emerging Markets High Profitability ETF
DEHP
$452M
| $1.32M | ﹤0.01% |
53,430
+3,388
| +7% | +$87.6K |
|
4264
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.82B
| $1.32M | ﹤0.01% |
16,377
-178,748
| -92% | -$14.9M |
|
4265
Farmers & Merchants Bancorp
FMAO
$483M
| $1.32M | ﹤0.01% |
44,830
+25,736
| +135% | +$769K |
|
4266
Matrix Service
MTRX
$335M
| $1.32M | ﹤0.01% |
110,181
+19,518
| +22% | +$239K |
|
4267
CALL
General Dynamics
GD
$107B
| $1.32M | ﹤0.01% |
5,000
| – | – |
|
|
4268
PUT
General Dynamics
GD
$107B
| $1.32M | ﹤0.01% |
5,000
| – | – |
|
4269
Sana Biotechnology
SANA
$1.06B
| $1.31M | ﹤0.01% |
806,635
-110,538
| -12% | -$330K |
|
4270
PUT
Community Health Systems
CYH
$423M
| $1.31M | ﹤0.01% |
439,400
| – | – |
|
4271
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$697M
| $1.31M | ﹤0.01% |
22,359
-3,283
| -13% | -$201K |
|
4272
Kodiak Sciences
KOD
$2.6B
| $1.31M | ﹤0.01% |
131,646
+86,998
| +195% | +$500K |
|
|
ITIC
4273
Investors Title Co
ITIC
$543M
| $1.3M | ﹤0.01% |
5,497
+2,237
| +69% | +$560K |
|
4274
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
| $1.3M | ﹤0.01% |
48,161
+2,257
| +5% | +$64.6K |
|
|
CTV
4275
DELISTED
Innovid Corp.
CTV
| $1.3M | ﹤0.01% |
420,974
+215,725
| +105% | +$509K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.